Disease Prevalence Target prevalence rate Imp Strategies Monitoring Classification Any imp notes

rate (Epi/End) (if any)

Lymphatic 13% (End) To eliminate LF from Nepal by 2030. Pahila 2020 ko plan -Mass Drug -Prevalence of -Only Brancroftian
filariasis thyo but fail bhayesi 2030 Administration disease filariasis present in Nepal.
Nepal is one with DEC and
out of 73 (microfilaria rate to below 1% or anti-genemia to less than Albendazole -Prevalence of -Lymphatic Filariasis
countries 2%) for 6 years infection Elimination Program of
where LF is (Not given to Nepal
endemic (by <2yr children). -Coverage of
WHO) Now-a-days, distribution of -Mapping of LF (dx) is
Ivermectin is drugs and done with ICT
Out of then 75 also included compliance of (Immunochromatography
districts of for 2-3 years intake test card)
Nepal, 61
have endemic -Morbidity (MDA with DEC -Hydrocele is the MC
LF Management and morbidity f/b
and Disability Albendazole ko elephantiasis
- Recently Prevention coverage: 65%
endemic: with
Rasuwa (1) Ivermectin,
DEC,
- Endemic Albendazole:
doubtful: 8 80%)
districts

- MDA
completed: 48

- MDA
ongoing: 15

- non
endemic: 5
Dengue -Nepal’s Dengue Control
Programme
Tuberculosis National TB Indicators 2020 2025 SDG End TB National Strategic Plan
prevalence 2030 2035 (Vision: TB Free Nepal by
survey, done 2030: “Ending TB" )
in 2018-19,
the first Death (redn 35% 75% 90% 95% End TB: when less than 1
nationwide TB by) TB patient per 10 lakh
survey, Incidence 20% 50% 80% 90% population
recorded: (redn by)
Catastrophic 0 0 0 0 NSP 2016-21 sakki sakyo
TB prevalence: cost and now we have 2021-
416 per 1lakh 26 NSP.
(1.8x higher
than estimate) @ DICe

TB incidence:
245 per 1 lakh
(1.6x higher
than estimate)

TB mortality:
17003 (3.1x
higher than
estimate)

Likewise, in
2078/79, NTP
recorded
28,677 cases
of TB.
MC region:
Terai (60%)

MC province:
Bagmati
province
 2018-19 ko National TB prevalence 2020-21 ko Factsheet 2016-21 ko plan 2021-26 ko plan
survey
TB incidence: 245 per 1 lakh 238 per 1 lakh Decrease incidence by 20% 181 per 1 lakh

TB prevalence: 416 per 1 lakh End TB epidemic by 2035, eliminate TB

by 2050
TB mortality: 17003 58 per 1 lakh 23 per 1 lakh

Strategies acc. to 2021-26 plan

1.Improve the quality of TB services and strengthen the health system to ensure universal access to TB services; implement TB services and support by increasing
community participation in TB management; and strengthen the digitalized case-based surveillance system in health care facilities.

(:jf:Yo k|0ffnL ;'b[9Ls/0f eO{ :jf:Yodf ;j{JofkL kx'Frsf nflu u'0f:tl/o Ifo/f]u ;]jfsf] ;'wf/ ug]{, Ifo/f]u Joj:yfkgdf ;d'bfosf] ;+nUgtf a[l2 u/L ;]jf tyf ;xof]unnfO{ k|
efjsf/L agfpg] / :jf:Yo ;+:yfx¿df la/fdLsf] lj:t[t ljj/0fdf cfwfl/t ljw'lto lgu/fgL k|0ffnLnfO{ ;'b[9Ls/0f ug]{.)

2.Strengthen laboratory services to further improve the management of TB diagnosis and treatment.
3.Quality Improvement of the services for TB prevention, identification and treatment.